Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126231091 | 12623109 | 1 | I | 2004 | 20160524 | 20160804 | 20160804 | EXP | US-DSJP-DSU-2016-117971 | DAIICHI | 0.00 | Y | 0.00000 | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126231091 | 12623109 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | ||||||
| 126231091 | 12623109 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | U | 21286 | TABLET | |||||||||
| 126231091 | 12623109 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25MG, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||||
| 126231091 | 12623109 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 126231091 | 12623109 | 5 | C | VIVELLE | ESTRADIOL | 1 | UNK | 0 | |||||||||||
| 126231091 | 12623109 | 6 | C | ESTRING | ESTRADIOL | 1 | UNK | 0 | |||||||||||
| 126231091 | 12623109 | 7 | C | RANITIDINE. | RANITIDINE | 1 | UNK | 0 | |||||||||||
| 126231091 | 12623109 | 8 | C | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
| 126231091 | 12623109 | 9 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG,QD | 0 | 25 | MG | TABLET | QD | |||||||
| 126231091 | 12623109 | 10 | C | LOTREL | AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE | 1 | 20 MG, QD | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126231091 | 12623109 | 1 | Product used for unknown indication |
| 126231091 | 12623109 | 3 | Hypertension |
| 126231091 | 12623109 | 4 | Product used for unknown indication |
| 126231091 | 12623109 | 5 | Product used for unknown indication |
| 126231091 | 12623109 | 6 | Product used for unknown indication |
| 126231091 | 12623109 | 7 | Product used for unknown indication |
| 126231091 | 12623109 | 8 | Product used for unknown indication |
| 126231091 | 12623109 | 9 | Hypertension |
| 126231091 | 12623109 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126231091 | 12623109 | HO |
| 126231091 | 12623109 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126231091 | 12623109 | Acute kidney injury | |
| 126231091 | 12623109 | Constipation | |
| 126231091 | 12623109 | Diverticulum | |
| 126231091 | 12623109 | Gastroenteritis | |
| 126231091 | 12623109 | Gastrooesophageal reflux disease | |
| 126231091 | 12623109 | Haemorrhoids | |
| 126231091 | 12623109 | Hiatus hernia | |
| 126231091 | 12623109 | Malabsorption | |
| 126231091 | 12623109 | Mesenteric vascular insufficiency | |
| 126231091 | 12623109 | Peptic ulcer haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126231091 | 12623109 | 1 | 2002 | 0 | ||
| 126231091 | 12623109 | 3 | 2004 | 2014 | 0 |